Skip Navigation
Search Menu

building exterior
 
Print This Page
Share this page: More
 

Skip Viragh Center for Pancreatic Cancer Clinical Research and Patient Care

Our collaborative team of scientists, physicians and allied health workers specialize in translating science learned in the laboratory into exceptional clinical care. Our center is a world leader in the diagnosis and management of pancreatic cancer, leading all institutions in novel therapies, innovative clinical trials and in training the next generation of pancreatic cancer experts.

The Pancreatic Cancer Multidisciplinary Clinic, a one-day visit for new patients to meet with experts and have a comprehensive treatment plan decided by a panel of specialists, was first developed at Johns Hopkins in 2009. To date we have treated more than 2,100 patients. Many institutions around the world have come here to learn and adopt this model.

Make an Appointment - 410-933-PANC(7262)

 

In understanding the science of cancer, investigators Bert Vogelstein, M.D., Kenneth Kinzler, Ph.D., and colleagues have deciphered the complete genetic blueprint for pancreatic cancer. Ralph Hruban, M.D., and Scott Kern, M.D., achieved the most advanced characterization of pancreatic cancer pathology.

In surgery, John Cameron, M.D., perfected the Whipple procedure, an operation to remove the head of the pancreas, most of the duodenum (a part of the small intestine), a portion of the bile duct, the gallbladder, and associated lymph nodes. Johns Hopkins surgeons now perform the most pancreatic cancer surgeries in the world.

In novel immunotherapies, Elizabeth Jaffee, M.D., developed the GVAX pancreatic cancer vaccine, now in clinical trials. Studies of what is likely to be the first immunotherapy for MSI-high tumors in pancreatic cancer approved by the FDA in 2017 was directed here.

 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

NCI CCC